Summary
Latest filing:
Anirvan Ghosh is Chief Executive Officer of Unity Biotechnology, Inc. (UBX). 1 SEC Form 4 filing on record, dated 6 November 2024. Most recent open-market trade: sold $557 of UBX on 6 November 2024. Lifetime open-market sales: $557.
Recent Transactions
1Every recent SEC Form 4 transaction Anirvan Ghosh has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Anirvan Ghosh. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alexander Hieu Nguyen - $192 of UBX open-market activity on record
- Lynne Marie Sullivan - $175 of UBX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Anirvan Ghosh?
Anirvan Ghosh is a corporate insider, tracked as Chief Executive Officer of Unity Biotechnology, Inc. (UBX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Anirvan Ghosh last file a Form 4?
The only primary Form 4 on record is dated 6 November 2024.
Has Anirvan Ghosh been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($557) across all tracked filings.
Where can I see all of Anirvan Ghosh's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Anirvan Ghosh and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
